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a b s t r a c t
An immunoperoxidase inhibition assay (IIA) for detection of rabies antibodies in human sera is described.
Diluted test sera are added to microplates with paraformaldehyde-ﬁxed, CER cells infected with rabies
virus. Antibodies in test sera compete with a rabies polyclonal rabbit antiserum which was added sub-
sequently. Next, an anti-rabbit IgG–peroxidase conjugate is added and the reaction developed by the
addition of the substrate 3-amino-9-ethylcarbazole (AEC). The performance of the assay was compared
to that of the “simpliﬁed ﬂuorescence inhibition microtest” (SFIMT), an established virus neutralization
assay, by testing 422 human sera. The IIA displayed 97.6% sensitivity, 98% speciﬁcity and 97.6% accu-
racy (Kappa correlation coefﬁcient =0.9). The IIA results can be read by standard light microscopy, where
the clearly identiﬁable speciﬁc staining is visible in antibody-negative sera, in contrast to the absence
of staining in antibody-positive samples. The assay does not require monoclonal antibodies or produc-
tion of large amounts of virus; furthermore, protein puriﬁcation steps or specialized equipment are not
necessary for its performance. The IIA was shown to be suitable for detection of rabies antibodies in
human sera, with sensitivity, speciﬁcity and accuracy comparable to that of a neutralization-based assay.
This assay may be advantageous over other similar methods designed to detect rabies-speciﬁc binding
antibodies, in that it can be easily introduced into laboratories, provided basic cell culture facilities are
available.
. Introduction
Antibodies to rabies virus can be detected by a variety of meth-
ds. The ﬁrst serological assay developed for detection of rabies
ntibodies was the mouse neutralization test (MNT) (Webster and
awson, 1935). The WHO Expert Committee on rabies still recom-
ends neutralization-based tests for rabies serology, since these
ere shown to correlate positively with protective responses (Cox,
982; Wiktor et al., 1973; Wunner et al., 1983).
Neutralization-based assays performed in vitro became widely
mployed for detection of rabies antibodies, in view of its prac-
icability in comparison to the MNT and, particularly, because no
nimal handling is required. Among such tests, the rapid ﬂuores-
ent focus inhibition test (RFFIT) was adopted as “gold standard”
y WHO (Smith et al., 1973). Other variations of the RFFIT, such
s the ﬂuorescence inhibition microtest (FIMT) (Zalan et al., 1979)
nd the ﬂuorescent antibody virus neutralization (FAVN) (Cliquet
t al., 1998)were developed. In Brazil, theMinistry ofHealth (2008)
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approved the use of a simpliﬁed version of the FIMT, called the sim-
pliﬁed ﬂuorescence inhibition microtest, or SFIMT (Favoretto et al.,
1993).More recently, neutralization assayshavebeen reported that
rely on immunoperoxidase for identiﬁcation of reactive and non-
reactive sera (Cardoso et al., 2004; Ogawa et al., 2008).
Nonetheless, there still remains the need for rapid and practi-
cal tests that might be applied in large scale serological studies. In
attempting to fulﬁl such a need, several enzyme linked immunoas-
says (ELISAs) have been developed (Thomas et al., 1963; Gough
and Dierks, 1971; Nicholson and Prestage, 1982; Mebatsion et al.,
1989; Zanetti et al., 1989; Esterhuysen et al., 1995; Elmgren and
Wandeler, 1996; Sugiyama et al., 1997; Cliquet et al., 2004; Bahloul
et al., 2005; Servat and Cliquet, 2006; Feyssaguet et al., 2007;
Muhamuda et al., 2007). These ELISAs detect binding antibodies,
and do not therefore necessarily correlate with neutralization or
protection from challenge. Most of them rely on antigens prepared
from infected cell extracts, while others use puriﬁed G protein
(Barton and Campbell, 1988; Zhang et al., 2009) or transformed
cell lines expressing the G protein (Zhang et al., 2009). However,
all such ELISAs require either the preparation of large volumes of
virus or puriﬁcation of viral proteins for antigen preparation. In the
present study, an alternative test for detection of rabies antibodies
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n human sera, the “immunoperoxidase inhibition assay” (IIA) is
eported. The IIA is a blocking assay based on the reaction between
est sera and rabies virus antigens in infected cells. Positive test
era will inhibit linkage of an anti-rabies polyclonal serum (pre-
ared in rabbits), which will then be revealed by the addition of an
nti-rabbit IgG/peroxidase conjugate. The IIA is described and its
erformance compared to a neutralization-based assay, the SFIMT.
. Materials and methods
.1. Serum samples
A total of 422 serum samples from persons with different rabies
accination histories were used in the study. Sera were inactivated
t 56 ◦C for 30min and tested in duplicate, in ﬁvefold dilutions. An
nternational reference serum (Pasteur Institute, São Paulo, Brazil)
as diluted to a ﬁnal concentration of 0.5 international units of
abies neutralizing antibodies per ml (IU/ml) and included in all
xperiments as positive control serum. The negative control serum
as collected from a person not previously vaccinated against
abies and diluted 1:2 for use in the assays.
The IIA results were expressed throughout the study in equiv-
lent units per ml of serum (EU/ml) by calibration against the
nternational reference serum. Antibody titres ≥0.5 EU/ml were
onsidered positive for rabies antibodies (WHO, 2005), whereas
ntibody titres <0.5 EU/ml were considered negative. Positive ref-
rence serum and negative controls were included in each batch of
ests.
.2. Cells
The “chicken embryo related” (CER) cell lineage (Cardoso et al.,
004) was used for the IIA. Cells were cultured in Eagle’s mini-
um essential medium (EMEM; Invitrogen) supplemented with
0% fetal bovine serum (Nutricell, Brazil) and antibiotics (100 IU/ml
enicillin, 100g/ml streptomycin). Cells were split once or twice
eekly.
For the SIMFT, production of virus stocks and testing proce-
ures were all carried out in “baby hamster kidney” (BHK-21) cells,
ultured as above.
.3. Viruses
For the IIA, rabies virus strain “PV” was multiplied in CER cells
Cardoso et al., 2004). One hundred, ﬁfty percent tissue culture
nfectious doses (TCID50) of strain PV were added in 200l vol-
mes to semiconﬂuent monolayers in 25 cm2 cell culture ﬂasks.
fter 60min at 37 ◦C for adsorption, 10ml of EMEM supplemented
s abovewere added andﬂasks incubated at 37 ◦C in a 5%CO2 atmo-
phere for 72h. Subsequently, cells were frozen and thawed once,
entrifuged for 15min at 3500× g to remove cell debris, aliquoted
n 300l volumes and stored at −70 ◦C until use.
For the SIMFT, strain PV was multiplied as above in BHK-21 cells
Batista et al., 2009).
The rabies virus strain CVS was used for challenge of vaccinated
abbits for productionof rabies antiserum. The viruswasmultiplied
n 3–4 weeks old mice following standard procedures (Koprowski,
996).
.4. Preparation of rabies polyclonal antiserum in rabbitsAll animal handling procedures were performed following the
uidelines for Animal Welfare of the Brazilian College for Experi-
entation onAnimals (COBEA). Rabbitswere inoculatedwith three
eekly doses of a commercially available rabies vaccine (Raiva-
el, Vallée, Brazil). Twenty–one days after the last immunization,gical Methods 174 (2011) 65–68
rabbits were challenged with 100 ﬁfty percent lethal doses (LD50)
of strain CVS. Serum was collected three weeks after challenge,
titrated and used as secondary antibody in the IIA. The appropriate
dilution of the polyclonal rabbit-anti-rabies serum to be used in
the IIA was determined by testing serial twofold dilutions of the
serum in the test with the positive reference serum (diluted to
0.5 IU/ml) and the antibody-negative control serum as source of
“blocking” antibodies (see Section 2.6 below). The highest serum
dilution capable of binding to antigen-containing cells with a clear
positive reaction after staining and a minimal background staining
(1:40) was chosen for use in subsequent tests.
2.5. Preparation of plates for the immunoperoxidase inhibition
assay (IIA)
CER cells were seeded in 96 well tissue culture plates (3–5×105
cells per well in 100l volume). After overnight growth, each well
was inoculated with 50l of a suspension containing 100 TCID50
of strain PV and plates incubated at 37◦ in a 5% CO2 atmosphere for
72h. Subsequently, the supernatant was removed and the plates
frozen at −20 ◦C in sealed bags for 1h. Plates were then removed
from the freezer and 100l/well of 4% paraformaldehyde in PBS
(8.5 g NaCl, 1.55 g Na2HPO4, 0.23 g NaH2PO4, H2O q.s.p. 1 l, pH
7.2) were added for 20min at room temperature. The monolay-
ers were then washed three times (see below) and submitted to
the IIA.
2.6. IIA procedure
All dilutionsof test sera, polyclonal rabbit-anti-rabies serumand
the anti-rabbit-IgG–peroxidase conjugate and controls were made
in dilution buffer (29.5 g NaCl; 1.55 g Na2HPO4; 0.23g NaH2PO4,
0.5% Tween 80, H2O q.s.p. 1 l). All washes were performed three
times with 100l/well of wash buffer (0.5% Tween 80 in PBS, pH
7.5). Test sera (diluted as in Section2.1 above)were added (indupli-
cate) to plateswithﬁxed, RABV-infectedmonolayers and incubated
for 1h at 37 ◦C. After incubation, plates were washed as above and
50l/well of an appropriate dilution (1:40) of polyclonal rabbit-
anti-rabies serum were added and plates incubated for 1h at 37 ◦C.
After incubation and washes, 50l of anti-rabbit-IgG–peroxidase
conjugate (1:150) were added to each well and incubated for an
additional hour. After another round of washes, the substrate 3-
amino-9-ethylcarbazole (AEC, Sigma) prepared as recommended
(Harlow and Lane, 1988) was added to the plates (50l/well). The
reaction was incubated at 37 ◦C for 15–40min depending on the
visible intensity of the staining, as judged by comparing speciﬁ-
cally stained wells (with negative control serum) and unstained
wells (with positive reference serum). The reaction was stopped
by removal of the substrate and addition of 100l of PBS. Plates
were read on a standard inverted microscope with a 20× mag-
niﬁcation objective. Test sera considered antibody-positive were
capable of inhibiting 100% of the binding of the polyclonal rabbit-
anti-rabies serum, thus precluding binding of the conjugate, giving
rise to unstained wells. Antibody-negative sera allowed binding of
anti-rabies serum and conjugate. The peroxidase conjugate reacts
withhydrogenperoxide in thepresenceof the substrateAEC,which
precipitates on the antigen-containing cells, allowing visualization
of the characteristic carmine red cytoplasmic staining. The anti-
body titres of the test sera were calculated on the basis of the last
dilution capable of blocking 100% of the speciﬁc staining. The test
was considered valid if the reference serum (diluted to 0.5 IU/ml)
was able to block 100% of the AEC color reaction by competing for
antigenwith the polyclonal rabies anti-serum. Likewise, polyclonal
rabies anti-serum binding should not be inhibited by the negative
control serum (diluted 1:2), shown by a colored reaction in the
wells.
H.B.C.R. Batista et al. / Journal of Virolo
Table 1
Comparison between the immunoperoxidase inhibition assay (IIA) and the simpli-
ﬁed ﬂuorescence inhibition microtest (SFIMT) for detection of rabies antibodies in
human sera (n=422).
IIA+ IIA− Total
SFIMT+ 361 9 370
SFIMT− 1 51 52
Total 362 60 422
Results for SFIMTexpressed in internationalunits/ml (IU/ml) aspositive (≥0.5 IU/ml)
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tr negative (<0.5 IU/ml). IIA results expressed in equivalent units/ml (EU/ml) as
ositive (≥0.5 EU/ml) or negative (<0.5 EU/ml). Accuracy: 97.6%; sensitivity: 97.6%;
peciﬁcity: 98.1%; positive predictive value: 99.7%; negative predictive value 85%.
ohen’s correlation coefﬁcient  =0.9.
.7. Simpliﬁed ﬂuorescence inhibition microtest (SFIMT)
rocedure
The SFIMT was performed as described previously (Favoretto
t al., 1993). Brieﬂy, twofold dilutions (1:10–1:320) of test sera
ere added to 96 well microplates. A viral suspension contain-
ng 80 TCID50 per 0.05ml of RABV strain PV (in 100l volumes)
as added to each well. After 1h incubation at 37 ◦C, BHK-21
ells (5×105 cells/well) were added (in 50l volumes) and the
icroplates incubated again for a further 24h at 37 ◦C. Subse-
uently, the supernatant was removed and the plates ﬁxed for
5min in 80% cold acetone. The ﬁxative was removed, the plates
ried and an appropriate dilution of ﬂuorescein-conjugated rabies
ntibodies (1:120 in PBS, pH 8.5) was added to wells (in 50l vol-
mes). After 1h incubation at 37 ◦C, plates were washed and 50l
f PBS-buffered glycerol (10% glycerol in PBS, pH 8.5) were added
o wells and read on a ﬂuorescence microscope.
.8. Statistical analysis
The results obtained by IIA were compared with those of SFIMT.
or calculation of the testıˇs sensitivity, speciﬁcity, accuracy, pre-
ictive positive and negative values and Cohen’s Kappa correlation
oefﬁcient, results from all the sera (n=422) were entered in the
AG Stat (Diagnostic and Agreement Statistics) spreadsheet in the
icrosoft Ofﬁce Excel program. Serum antibody titres were cal-
ulated by the method of Reed and Muench (1938). SFIMT results
ere expressed in IU/ml, whereas IIA results were expressed in
U/ml. Antibody titres ≥0.5 EU/ml were considered positive for
abies antibodies, whereas antibody titres <0.5 EU/ml were con-
idered negative for rabies antibodies.
. Results
Of the 422 sera examined, 370 were considered positive
≥0.5 IU/ml) as determined by the SFIMT, while 361 were positive
y the IIA (≥0.5 EU/ml). Fifty samplesnegative in SFIMT (<0.5 IU/ml)
ere also negative by IIA; only one sample negative in SFIMT
esulted positive in IIA (Table 1). The disagreement between IIA
nd SFIMT was 2.4% (10/422), represented by nine false negative
nd the false positive sera. The majority of the unmatched neg-
tive results (7/9; 77.8%) were obtained in sera with low SFIMT
ntibody titres (range 0.53–0.8 EU/ml, mean=0.65, SD=0.19). The
omparison between results obtained in IIA and SFIMT is shown in
able 1.
. DiscussionThe WHO guidelines recommend tests capable of detecting
eutralizing antibodies for rabies serology, since the amount of
eutralizing antibodies has been shown to correlate with protec-
ion to challenge (Smith et al., 1973, 1996; Cliquet et al., 1998).gical Methods 174 (2011) 65–68 67
Such tests, however, may still be tedious and complicated to per-
form, making them unsuitable for large-scale sero-epidemiological
surveys. In such cases, the plethora of ELISAs available for rabies
serology becomes rather attractive (Bahloul et al., 2005; Cliquet
et al., 2004; Elmgren and Wandeler, 1996; Esterhuysen et al., 1995;
Feyssaguet et al., 2007; Mebatsion et al., 1989; Nicholson and
Prestage, 1982; Servat and Cliquet, 2006; Sugiyama et al., 1997;
Muhamuda et al., 2007) since these are easy to perform and fairly
adaptable to large screening studies.
However, in contrast toneutralization-based tests, ELISAsdetect
antibodies that bind to viral antigens, regardless of the neutraliz-
ing capacity of such antibodies. In consequence, binding antibodies
do not necessarily correlate with protection, which is essentially
the main reason for performing serology in vaccinated individu-
als. In view of that, ELISAs, have to be compared with the “gold
standard” represented by virus neutralization assays, such as the
RFFIT (Smith et al., 1973). On this basis, it has been assumed that
the closer the correlation of ELISAs or other binding assays with
neutralization-based assays, the more suitable these might be for
rabies serology. In such comparisons, many of the above men-
tioned ELISAs, including some commercial kits, performed poorly
(Bahloul et al., 2005; Servat and Cliquet, 2006; Niederhauser et al.,
2008). Some investigators attempted to overcome this problem by
developing ELISAswith neutralizingmonoclonal antibodies to viral
glycoprotein G (the major protein responsible for the induction of
neutralizing antibodies), or the N protein, which elicits some neu-
tralizing activity (Sugiyama et al., 1997; Muhamuda et al., 2007).
However, these may be difﬁcult to obtain or purchase and are not
available widely.
In the present study, the IIA was compared with the SFIMT, an
established virus neutralization assay currently in use in Brazil and
validated previously against the RFFIT (Favoretto et al., 1993). The
SFIMT is performed routinely at the rabies national reference lab-
oratory (Pasteur Institute, São Paulo, Brazil), where it was adopted
for monitoring rabies antibodies in vaccinated persons (Ministry of
Health, 2008). In the comparison, the IIA displayed a strong corre-
lation with the SFIMT (Cohen’s Kappa correlation coefﬁcient: 0.9),
with excellent sensitivity (97.6%) and speciﬁcity (98.1%). Only ten
out of the 422 sera (2.4%) examined in this study presented dis-
crepant results, of which only two had neutralizing antibody titres
>1EU/ml at SIMFT.
The IIA introduced in the present study is a simple blocking
assay that relies on the ability of antibodies in the test sera to
block binding of a polyclonal rabies serum produced in rabbits. It
does not utilize competing monoclonal antibodies. The polyclonal
rabies serum required can be prepared locally with relative ease, a
straightforward task formost laboratoriesdealingwith rabies virus.
The IIA does not require preparation of large volumes of virus nor
puriﬁcation of viral proteins for antigen preparation. In addition,
it does not require expensive equipment for antigen preparation,
such as high-speed or ultracentrifuges. In addition, it does not
require ELISA plate readers, since it does not rely on a soluble color
reaction for its reading. As the substrate AEC is insoluble, it remains
attached to antigen-containing cells, so labelled infected cells can
be easily identiﬁed by the distinctive carmine red color. Therefore,
readings can be performed with the aid of a regular optical micro-
scope with a 20× or 40× objective magniﬁcation. In addition, the
staining proﬁle, or absence of staining in antibody positive wells,
serves as an additional indicator of the speciﬁcity of the reaction,
which decreases the chances of misinterpretation of results. This
advantage provided by AEC has also been explored in recent neu-
tralization assays revealed by immunoperoxidase (Cardoso et al.,
2004; Ogawa et al., 2008). In addition, rather than relying on the
inhibition of 50% or 70% of ﬂuorescent foci, as in RFFIT or FAVN, the
test is read as either antibody positive, when no stained cells are
visible in a well, or antibody negative when any focus of stained
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ells in a well is scored as virus positive. This makes interpretation
imple and less dependent on operator subjectivity.
Another advantageof the IIA is that, as ablockingassay, itmaybe
otentially useful for the detection of antibodies in different animal
pecies. This can be particularly useful when screening for rabies
ntibodies in exotic or wild species, where anti-species conjugates
re not readily available.
In conclusion, the IIA performance was highly satisfactory for
etection of rabies antibodies in human sera. The test is of relatively
ow cost and does not require expensive equipment or reagents;
nly basic cell culture facilities are required. The results are eas-
ly read in an ordinary optical microscope and interpretation is
traightforward, with reading based on an “all or nothing” prin-
iple. When compared to the SFIMT, a strong positive correlation
as found. As the IIA is basedonablocking reaction, itmight also be
otentially useful for detecting rabies antibodies in other species.
tudies are on the way to evaluate such use for the IIA.
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